These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31989684)

  • 1. Health professionals' views about who would benefit from using a closed-loop system: a qualitative study.
    Lawton J; Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Randell T; Besser REJ; Trevelyan N; Hovorka R;
    Diabet Med; 2020 Jun; 37(6):1030-1037. PubMed ID: 31989684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial.
    Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Ghatak A; Randell T; Besser REJ; Trevelyan N; Hovorka R; Lawton J
    Diabetes Technol Ther; 2020 Jun; 22(6):468-475. PubMed ID: 32048877
    [No Abstract]   [Full Text] [Related]  

  • 3. A qualitative study of clinician attitudes towards closed-loop systems in mainstream diabetes care in England.
    Farrington C; Murphy HR; Hovorka R
    Diabet Med; 2020 Jun; 37(6):1023-1029. PubMed ID: 31943318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England.
    Farrington C; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2020 May; 22(5):404-410. PubMed ID: 31913061
    [No Abstract]   [Full Text] [Related]  

  • 5. Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and Solutions.
    Rankin D; Hart RI; Kimbell B; Barnard-Kelly K; Brackenridge A; Byrne C; Collett C; Dover AR; Hartnell S; Hunt KF; Lee TTM; Lindsay RS; McCance DR; McKelvey A; Rayman G; Reynolds RM; Scott EM; White SL; Hovorka R; Murphy HR; Lawton J
    Diabetes Technol Ther; 2023 Apr; 25(4):260-269. PubMed ID: 36662589
    [No Abstract]   [Full Text] [Related]  

  • 6. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
    Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
    Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial.
    Lawton J; Kirkham J; Rankin D; White DA; Elliott J; Jaap A; Smithson WH; Heller S;
    Diabet Med; 2016 Feb; 33(2):243-51. PubMed ID: 26248590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do-it-yourself closed-loop systems for people living with type 1 diabetes.
    Dowling L; Wilmot EG; Choudhary P
    Diabet Med; 2020 Dec; 37(12):1977-1980. PubMed ID: 32420640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes.
    Hng TM; Burren D
    Intern Med J; 2018 Nov; 48(11):1400-1404. PubMed ID: 30387315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study.
    Lawton J; Rankin D; Hartnell S; Lee T; Dover AR; Reynolds RM; Hovorka R; Murphy HR; Hart RI;
    Diabet Med; 2023 May; 40(5):e15072. PubMed ID: 36807582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management.
    Lawton J; Blackburn M; Rankin D; Werner C; Farrington C; Hovorka R; Hallowell N
    AJOB Empir Bioeth; 2019; 10(2):100-112. PubMed ID: 30986113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.
    Uduku C; Oliver N
    Curr Opin Pharmacol; 2017 Oct; 36():29-33. PubMed ID: 28802779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staff experiences of closing out a clinical trial involving withdrawal of treatment: qualitative study.
    Lawton J; White D; Rankin D; Elliott J; Taylor C; Cooper C; Heller S; Hallowell N
    Trials; 2017 Feb; 18(1):61. PubMed ID: 28173843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.
    Musolino G; Allen JM; Hartnell S; Wilinska ME; Tauschmann M; Boughton C; Campbell F; Denvir L; Trevelyan N; Wadwa P; DiMeglio L; Buckingham BA; Weinzimer S; Acerini CL; Hood K; Fox S; Kollman C; Sibayan J; Borgman S; Cheng P; Hovorka R
    BMJ Open; 2019 Jun; 9(6):e027856. PubMed ID: 31164368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring and pumps.
    Cohen N
    Aust Fam Physician; 2015 May; 44(5):284-7. PubMed ID: 26042400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.